These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6779333)

  • 41. Further evidence for GABA-ergic mechanisms in the action of benzodiazepines.
    Zakusov VV; Ostrovskaya RU; Kozhechkin SN; Markovich VV; Molodavkin GM; Voronina TA
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):313-26. PubMed ID: 23084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Role of GABA-ergic and dopaminergic mechanisms in the withdrawal syndrome after discontinuation of long-term phenazepam administration].
    Voronina TA; Garibova TL
    Biull Eksp Biol Med; 1980 Jul; 89(7):41-3. PubMed ID: 6773598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of alterations in the metabolism of gamma-aminobutyrate on convulsant potencies.
    Stone WE
    Epilepsia; 1977 Dec; 18(4):507-15. PubMed ID: 338297
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice.
    Zarrindast MR; Mousa-Ahmadi E
    Eur J Pharmacol; 1999 Sep; 381(2-3):129-33. PubMed ID: 10554880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spinal and supraspinal components of GABAergic inhibition of the micturition reflex in rats.
    Maggi CA; Furio M; Santicioli P; Conte B; Meli A
    J Pharmacol Exp Ther; 1987 Mar; 240(3):998-1005. PubMed ID: 3559989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of phenoxybenzamine on the GABA system and on convulsive activity.
    Pericić D; Manev H
    Neuropsychobiology; 1983; 10(1):23-8. PubMed ID: 6657036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular effects of GABA, GABA-aminotransferase inhibitors and valproic acid following systemic administration in rats, cats and dogs: pharmacological approach to localize the site of action.
    Löscher W
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):32-58. PubMed ID: 6810779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissociation between drug-induced increases in nerve terminal and non-nerve terminal pools of GABA in vivo.
    Iadarola MJ; Gale K
    Eur J Pharmacol; 1979 Oct; 59(1-2):125-9. PubMed ID: 389641
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Possible involvement of the central GABAergic system in pentobarbital-stimulated gastric acid secretion in the perfused rat stomach preparation.
    Lin WC; Yano S; Watanabe K
    Eur J Pharmacol; 1988 Apr; 149(1-2):33-9. PubMed ID: 3396625
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of GABA antagonists on the pentobarbital-induced depression of respiration and cough in rats.
    Kamei J; Ogawa M; Kasuya Y
    Pharmacol Biochem Behav; 1989 Jan; 32(1):357-60. PubMed ID: 2543992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of GABA-ergic drugs on enkephalin-induced motor seizure phenomena in the rat.
    Dzoljic MR; v d Poel-Heisterkamp AL
    Clin Exp Pharmacol Physiol; 1981; 8(2):141-50. PubMed ID: 6265125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral aspects of GABAergic-dopaminergic interactions in the central nervous system.
    Sandoval MR; Palermo-Neto J
    Eur J Pharmacol; 1989 Aug; 167(1):117-25. PubMed ID: 2776839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dipropylacetate-induced shaking behaviour in the rat: a role of spinal alpha 2-adrenoceptors.
    Van der Laan JW; Dirksen R
    Eur J Pharmacol; 1988 Aug; 152(3):197-205. PubMed ID: 2905999
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticonvulsant and antiaggressive properties of di-n-propyl acetate after repeated treatment.
    Simler S; Ciesielski L; Klein M; Mandel P
    Neuropharmacology; 1982 Feb; 21(2):133-40. PubMed ID: 6801539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat. Correlation to pharmacological activities.
    Löscher W; Vetter M
    Biochem Pharmacol; 1985 May; 34(10):1747-56. PubMed ID: 3924047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MDL 27,531 selectively reverses strychnine-induced seizures in mice.
    Kehne JH; Kane JM; Miller FP; Ketteler HJ; Braun DL; Senyah Y; Chaney SF; Abdallah A; Dudley MW; Ogden AM
    Br J Pharmacol; 1992 Aug; 106(4):910-6. PubMed ID: 1327393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropharmacology of amide derivatives of P-GABA.
    Habibuddin M; Pal M; Pal SP
    Indian J Exp Biol; 1992 Jul; 30(7):578-82. PubMed ID: 1459630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antagonism of gamma-aminobutyric acid and muscimol by picrotoxin, bicuculline, strychnine, bemegride, leptazol, D-tubocurarine and theophylline in the isolated olfactory cortex.
    Scholfield CN
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Mar; 318(4):274-80. PubMed ID: 7078662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Block of glutamate decarboxylase decreases GABAergic inhibition at the crayfish synapses: possible role of presynaptic metabotropic mechanisms.
    Golan H; Grossman Y
    J Neurophysiol; 1996 May; 75(5):2089-98. PubMed ID: 8734605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of dopaminergic and GABA-ergic interactions in seizure susceptibility.
    György L
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):280-6. PubMed ID: 526081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.